Prentice-Lewis Clinical Research Study
Continued from previous page

Without a viable technology such as the MMC-2000™ system, large protein molecules are simply too large to pass through the mucous membranes and / or the stomach lining intact.

HUMAN SUBJECTS AND METHODS
Out of the 66 survey subjects, three (3) subjects did not qualify, because they failed to provide baseline data and/or failed to complete a subsequent survey showing change over time.

There were a total of 63 qualifying subjects: 22 men and 41 women.

Most of the subjects reporting were over 40 years of age with an age range of 25 to 79 years.

PROCEDURES
A subjective outcome-based Questionnaire was sent out with over 2,200 customer orders. Of the 2,200 customer orders fulfilled, 94 customers responded with written testimonials and/or survey data.

Out of the approximately 2,200 customers, there were 22 refunds given to dissatisfied customers. Reasons for refunds included:

(1) No result after 30 days (11 people)
(2) Negative results (3 people)
(3) Doctor recommendation to stop taking product (2 people)
(4) Dissatisfaction with product taste (3 people)
(5) Simply needed the money returned (3 people).

Survey subjects were encouraged to complete the survey regardless of their product experience. In fact, subjects that requested a refund were required to submit a written explanation or complete the survey in order to qualify for a refund.

The survey asked subjects to rate each of the following 37 mental and physical health criteria on a scale of 1-7, where:

1 is very poor/least/worst
2 is poor
3 is fair/average
4 is good/better
5 is very good/improved
6 is excellent/great
7 has never been better

In addition, subjects were invited to provide some optional objective information, which included: (1) Age; (2) Weight; and (3) Height.

CONTROLS
In order to be included in the survey, subjects needed to have completed the health survey at a minimum of two distinct times: immediately prior to supplementation with the proprietary micro-dilution oral spray Growth Factor-MMC system (i.e. Baseline), and after 1 month of consistent supplementation. Most subjects also completed the survey after 1 week of use and many submitted subsequent months evaluations. A comparison placebo control group was not utilized.

Ingredients
The proprietary micro-dilution oral spray Growth Factor-MMC supplement used in the survey contained between 600 and 2,000 nanograms per milliliter (ng/ml) of bioactive Growth Factors complexed to the MMC transport macro-molecule.

The Growth Factor-MMC formula contained 2,000 ng/ml of the proprietary micro-dilution oral spray Growth Factor-MMC system, 2,000 ng/ml of GHRFC^g, trace minerals (calcium, sodium, sulfur, silica), sodium benzoate, potassium sorbate, and distilled water.

RESULTS
Baseline and final ratings for each health category were analyzed. Each of the 37 distinct health areas for the 63 qualifying surveyed subjects were rated between 1 and 7 as described above.

Improvement Over Time
As people continued to use the product, many did not continue to complete the health surveys.

The following is an assessment of how many subjects completed survey data for each time period:

^g GHRFC: Growth Hormone Releasing Factor Complex

Continued on next page